0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Research Letter |

Parental Absence From Clinic Predicts Human Immunodeficiency Virus Treatment Failure in Adolescents FREE

Elizabeth D. Lowenthal, MD, MSCE1,2,3,4; Tafireyi Marukutira, MBChB, MPH, MPhil3; Ontibile Tshume, BA3; Jennifer Chapman, MPH4; Jean B. Nachega, MD, PhD, MPH, DTM&H5; Gabriel Anabwani, MBChB, MMed, MSc3; Robert Gross, MD, MSCE2,6
[+] Author Affiliations
1Departments of Pediatrics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia
2Botswana-UPenn Partnership, Gaborone, Botswana
3Botswana-Baylor Children’s Clinical Centre of Excellence, Gaborone, Botswana
4Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania
5University of Pittsburgh, Pittsburgh, Pennsylvania
6Departments of Medicine and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia
JAMA Pediatr. 2015;169(5):498-500. doi:10.1001/jamapediatrics.2014.3785.
Text Size: A A A
Published online

It is estimated that more than 2.1 million adolescents (10-19 years of age) live with human immunodeficiency virus (HIV) in low-income and middle-income countries.1 When compared with both adults and younger children, HIV-infected adolescents have higher rates of nonadherence, virologic failure, and death.2,3 As they age, adolescents generally increase their health care–related autonomy. Adolescents may attend a clinic with or without an adult caregiver (parent). The relationship between parental attendance at clinic visits and adolescent chronic disease outcomes is unknown. We hypothesized that routine clinic attendance without a parent would be associated with the risk of HIV treatment failure, particularly in younger adolescents.

METHODS

Three hundred predominantly perinatally HIV-infected adolescents (10-19 years of age) receiving HIV treatment at the Botswana-Baylor Children’s Clinical Centre of Excellence were followed up at their quarterly clinic visits in a longitudinal adherence study beginning in 2012. Enrollment was stratified to include 50 adolescents with detectable viral loads (VLs) at entry, approximating the proportion of patients in the underlying population with detectable VLs. Human immunodeficiency virus RNA levels (VLs) were obtained at each visit. Institutional review board approval was obtained from the Botswana Health Research Development Committee, the University of Pennsylvania Institutional Review Board, and the Baylor College of Medicine Institutional Review Board. A parent or guardian was present at the study entry visit to consent to each adolescent’s participation. Written informed consent was obtained from the parents and written assent was obtained from the adolescents. After the initial visit, parents were present only if they would otherwise attend routine clinic visits. The relative risk of virologic failure (VL ≥ 400 copies/mL) at 3 months or 6 months of follow-up was calculated for adolescents with and without a parent present at the 3-month study visit. Multivariable logistic regression was used to assess for confounding by age, sex, time receiving treatment, and orphan status. Linear regression was used to evaluate the likelihood of virologic failure with increasing age for those with and without a parent present.

RESULTS

For the 300 enrolled participants, the median age was 13.4 years (interquartile range, 11.8-15.6 years) with a median time of receiving HIV treatment of 7.5 years (interquartile range, 5.3-8.8 years). Of the participants, 158 were female (52.7%). There were 85 maternal orphans (28.3%), 70 paternal orphans (23.3%), and 50 double orphans (16.7%). Two hundred thirty-eight participants (79%) were World Health Organization clinical stage 3 or 4 (advanced or severe disease) at the treatment baseline and 199 participants (66%) had advanced or severe immunologic suppression. However, at study entry, 267 participants (89%) had been asymptomatic for at least 6 months. The Table shows the number (percentage) of patients with and without a parent present at 3 months and 6 months of follow-up who had a detectable HIV VL. One participant was excluded because he ran away from home and did not come to the 3-month and 6-month study visits.

Table Graphic Jump LocationTable.  HIV VLs and Missing Parents for 299 Adolescents

The odds of failure at the 3-month visit if a parent was not present were 4.5 (95% CI, 1.5-4.1) compared with those with a parent present at 3 months. There was no confounding by sex, time receiving treatment, or orphan status. Controlling for age decreased the odds of virologic failure from 4.5 to 3.6 (95% CI, 1.5-8.4) for those without vs with a parent present at 3 months. The Figure illustrates the difference in proportion of patients with virologic failure by age stratified by the presence/absence of a parent in the clinic at the 3-month visit.

Place holder to copy figure label and caption
Figure.
Proportion of Patients With Virologic Failure by Age Stratified by Parental Absence

The shaded areas indicate 95% CI bands.

Graphic Jump Location

DISCUSSION

Absence of a parent from an adolescent’s clinic visit was strongly associated with HIV virologic failure. These results suggest that interventions to identify potentially supportive caregivers and strengthen adolescent/parent dyads might lower adolescents’ risk of treatment failure. In settings where psychosocial support resources are limited, targeting adolescents who attend clinics alone might help the most vulnerable youth with HIV and other chronic diseases.

ARTICLE INFORMATION

Corresponding Author: Elizabeth Lowenthal, MD, MSCE, Perelman School of Medicine, Departments of Pediatrics and Epidemiology, University of Pennsylvania, 3535 Market St, Room 1513, Philadelphia, PA 19104 (lowenthale@email.chop.edu).

Published Online: March 30, 2015. doi:10.1001/jamapediatrics.2014.3785.

Author Contributions: Dr Lowenthal and Ms Chapman had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.

Study concept and design: Lowenthal, Nachega, Gross.

Acquisition, analysis, or interpretation of data: All authors.

Drafting of the manuscript: Lowenthal, Marukutira.

Critical revision of the manuscript for important intellectual content: All authors.

Statistical analysis: Lowenthal, Nachega, Gross.

Obtained funding: Lowenthal.

Administrative, technical, or material support: Tshume, Anabwani, Gross.

Study supervision: Lowenthal, Marukutira, Chapman.

Conflict of Interest Disclosures: None reported.

Funding/Support: Dr Lowenthal is supported through career development award K23 MH095669 from the National Institute of Mental Health. Dr Gross receives support from grant P30 A1 045008 from the Penn Center for AIDS Research.

Role of the Funder/Sponsor: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

Additional Contributions: We thank the adolescents and families at the Botswana-Baylor Children’s Clinical Centre of Excellence who shared their experiences as part of the adolescent Ba Nana Adherence Study as well as the Botswana-Baylor staff and, in particular, the Ba Nana Adherence Study staff.

REFERENCES

Joint United Nations Programme on HIV/AIDS. Report on the Global AIDS Epidemic. Geneva, Switzerland; World Health Organization: 2013.
Lowenthal  ED, Bakeera-Kitaka  S, Marukutira  T, Chapman  J, Goldrath  K, Ferrand  RA.  Perinatally acquired HIV infection in adolescents from sub-Saharan Africa: a review of emerging challenges. Lancet Infect Dis. 2014;14(7):627-639.
PubMed   |  Link to Article
Health for the World's Adolescents: A Second Chance in the Second Decade. Geneva, Switzerland: World Health Organization; 2014.

Figures

Place holder to copy figure label and caption
Figure.
Proportion of Patients With Virologic Failure by Age Stratified by Parental Absence

The shaded areas indicate 95% CI bands.

Graphic Jump Location

Tables

Table Graphic Jump LocationTable.  HIV VLs and Missing Parents for 299 Adolescents

References

Joint United Nations Programme on HIV/AIDS. Report on the Global AIDS Epidemic. Geneva, Switzerland; World Health Organization: 2013.
Lowenthal  ED, Bakeera-Kitaka  S, Marukutira  T, Chapman  J, Goldrath  K, Ferrand  RA.  Perinatally acquired HIV infection in adolescents from sub-Saharan Africa: a review of emerging challenges. Lancet Infect Dis. 2014;14(7):627-639.
PubMed   |  Link to Article
Health for the World's Adolescents: A Second Chance in the Second Decade. Geneva, Switzerland: World Health Organization; 2014.

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

639 Views
2 Citations
×

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
Jobs
JAMAevidence.com

Care at the Close of Life: Evidence and Experience
Overcoming the False Dichotomy of Curative vs Palliative Care for Late-Stage HIV/AIDS: "Let Me Live the Way I Want to Live, Until I Can't"

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
Evidence to Support the Update